Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry

NCT04279496 · tracked via the Priya Life Science USA tracker

Sponsor

Cleerly, Inc.

Phase

Observational

Started

2020-06-01

Last updated

2026-06-05

Condition(s) studied

Coronary Artery Disease

Study summary

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Age \>18 years * Undergoing clinically indicated CCTA with \>64-detector row CT * Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation Exclusion Criteria: * Individuals unable to provide informed consent * Non-cardiac illness with life expectancy \< 2 years * Pregnancy

Primary outcome measure(s)

Coronary CT Angiography EvaluatioN For Clinical Outcomes — June 2020- June 2022
Examined the totality of information visualized by coronary CT angiography (CCTA) for optimal refinement of prognostic risk stratification

Trial sites (1)

Facility	City	Region	Status
University of Virginia	Charlottesville	Virginia

More Cleerly, Inc. trials in the USA

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events Recruiting

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD Active, not recruiting

Other trials for the same condition

AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management Active, not recruiting

Prevail Global Study Recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial Active, not recruiting

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. Recruiting

RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04279496 on ClinicalTrials.gov ↗ ← All trials in the USA